GIP and type 2 diabetes mellitus: It has been shown that in patients with type 2 diabetes mellitus (T2DM) the response to the incretin effect is altered as a result of a severe defect in the sensitivity for GIP in the β cells [4] and a reduction in food-induced GLP-1 secretion [5, 6].